Status:
UNKNOWN
Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Lead Sponsor:
Xijing Hospital
Collaborating Sponsors:
Air Force Military Medical University, China
Xi'an Jiaotong University
Conditions:
Liver Cirrhosis
Carcinoma, Hepatocellular
Eligibility:
All Genders
20-90 years
Brief Summary
The purpose of this study is to investigate the impact of splenectomy coupled with portal-azygous disconnection on hepatocarcinogenesis in patients with post-hepatitic cirrhosis after hepatitis B or C...
Detailed Description
A case-control study was carried out. The factors studied include age, gender, ascites, hepatic encephalopathy, ALT, AST, TBIL, ALP, GGT, Child-Pugh classification of liver function, and history of sp...
Eligibility Criteria
Inclusion
- after surgery
Exclusion
- without surgery
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01201655
Start Date
January 1 2010
End Date
December 1 2012
Last Update
September 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chen yong
Xi'an, Shaanxi, China, 710032